Literature DB >> 31283437

Regulation of Latency in the Human T Cell Leukemia Virus, HTLV-1.

Charles R M Bangham1, Michi Miura1, Anurag Kulkarni1, Masao Matsuoka2,3.   

Abstract

The human T cell leukemia virus persists in vivo in 103 to 106 clones of T lymphocytes that appear to survive for the lifetime of the host. The plus strand of the provirus is typically transcriptionally silent in freshly isolated lymphocytes, but the strong, persistently activated cytotoxic T lymphocyte (CTL) response to the viral antigens indicates that the virus is not constantly latent in vivo. There is now evidence that the plus strand is transcribed in intense intermittent bursts that are triggered by cellular stress, modulated by hypoxia and glycolysis, and inhibited by polycomb repressive complex 1 (PRC1). The minus-strand gene hbz is transcribed at a lower, more constant level but is silent in a proportion of infected cells at a given time. Viral genes in the sense and antisense strands of the provirus play different respective roles in latency and de novo infection: Expression of the plus-strand gene tax is essential for de novo infection, whereas hbz appears to facilitate survival of the infected T cell clone in vivo.

Entities:  

Keywords:  cell stress; epigenetics; gene burst; latency; reservoir; retrovirus

Mesh:

Substances:

Year:  2019        PMID: 31283437     DOI: 10.1146/annurev-virology-092818-015501

Source DB:  PubMed          Journal:  Annu Rev Virol        ISSN: 2327-056X            Impact factor:   10.431


  16 in total

1.  Antitumor effects of chloroquine/hydroxychloroquine mediated by inhibition of the NF-κB signaling pathway through abrogation of autophagic p47 degradation in adult T-cell leukemia/lymphoma cells.

Authors:  Yanuar Rahmat Fauzi; Shingo Nakahata; Syahrul Chilmi; Tomonaga Ichikawa; Phawut Nueangphuet; Ryoji Yamaguchi; Tatsufumi Nakamura; Kazuya Shimoda; Kazuhiro Morishita
Journal:  PLoS One       Date:  2021-08-18       Impact factor: 3.240

2.  HTLV-1 contains a high CG dinucleotide content and is susceptible to the host antiviral protein ZAP.

Authors:  Paola Miyazato; Misaki Matsuo; Benjy J Y Tan; Michiyo Tokunaga; Hiroo Katsuya; Saiful Islam; Jumpei Ito; Yasuhiro Murakawa; Yorifumi Satou
Journal:  Retrovirology       Date:  2019-12-16       Impact factor: 4.602

Review 3.  HTLV-1 infection of myeloid cells: from transmission to immune alterations.

Authors:  Brenda Rocamonde; Auriane Carcone; Renaud Mahieux; Hélène Dutartre
Journal:  Retrovirology       Date:  2019-12-23       Impact factor: 4.602

4.  In vivo dynamics and adaptation of HTLV-1-infected clones under different clinical conditions.

Authors:  Mikiko Izaki; Jun-Ichirou Yasunaga; Kisato Nosaka; Kenji Sugata; Hayato Utsunomiya; Youko Suehiro; Takafumi Shichijo; Asami Yamada; Yasuhiko Sugawara; Taizo Hibi; Yukihiro Inomata; Hirofumi Akari; Anat Melamed; Charles Bangham; Masao Matsuoka
Journal:  PLoS Pathog       Date:  2021-02-01       Impact factor: 6.823

Review 5.  Immunopathogenesis and Cellular Interactions in Human T-Cell Leukemia Virus Type 1 Associated Myelopathy/Tropical Spastic Paraparesis.

Authors:  Sepehr Aghajanian; Majid Teymoori-Rad; Ghazale Molaverdi; Sayed-Hamidreza Mozhgani
Journal:  Front Microbiol       Date:  2020-12-22       Impact factor: 5.640

Review 6.  CRISPR Genome Editing Applied to the Pathogenic Retrovirus HTLV-1.

Authors:  Amanda R Panfil; Patrick L Green; Kristine E Yoder
Journal:  Front Cell Infect Microbiol       Date:  2020-12-23       Impact factor: 5.293

7.  M-Sec induced by HTLV-1 mediates an efficient viral transmission.

Authors:  Masateru Hiyoshi; Naofumi Takahashi; Youssef M Eltalkhawy; Osamu Noyori; Sameh Lotfi; Jutatip Panaampon; Seiji Okada; Yuetsu Tanaka; Takaharu Ueno; Jun-Ichi Fujisawa; Yuko Sato; Tadaki Suzuki; Hideki Hasegawa; Masahito Tokunaga; Yorifumi Satou; Jun-Ichirou Yasunaga; Masao Matsuoka; Atae Utsunomiya; Shinya Suzu
Journal:  PLoS Pathog       Date:  2021-11-29       Impact factor: 6.823

8.  Role of the cellular factor CTCF in the regulation of bovine leukemia virus latency and three-dimensional chromatin organization.

Authors:  Maxime Bellefroid; Anthony Rodari; Mathilde Galais; Peter H L Krijger; Sjoerd J D Tjalsma; Lorena Nestola; Estelle Plant; Erica S M Vos; Sara Cristinelli; Benoit Van Driessche; Caroline Vanhulle; Amina Ait-Ammar; Arsène Burny; Angela Ciuffi; Wouter de Laat; Carine Van Lint
Journal:  Nucleic Acids Res       Date:  2022-04-08       Impact factor: 16.971

Review 9.  Strategies for Targeting Retroviral Integration for Safer Gene Therapy: Advances and Challenges.

Authors:  Kristine E Yoder; Anthony J Rabe; Richard Fishel; Ross C Larue
Journal:  Front Mol Biosci       Date:  2021-05-12

Review 10.  Latency Reversing Agents: Kick and Kill of HTLV-1?

Authors:  Annika P Schnell; Stephan Kohrt; Andrea K Thoma-Kress
Journal:  Int J Mol Sci       Date:  2021-05-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.